Company Medimarcprax Srl with Fiscal Code 36443483
recorded a turnover of 2024 of
52.752,
with a net profit of
40.422
and having an average number of employees of
1.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Medimarcprax Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
18.322
20.698
22.726
60.974
21.586
28.638
42.046
29.240
52.752
Total Income - EUR
-
18.323
22.156
22.767
61.694
22.285
28.830
42.312
29.496
52.752
Total Expenses - EUR
-
237
1.234
9.838
891
3.754
6.368
1.689
8.785
10.779
Gross Profit/Loss - EUR
-
18.085
20.922
12.928
60.804
18.531
22.462
40.623
20.711
41.973
Net Profit/Loss - EUR
-
17.536
20.275
12.701
60.189
18.308
22.174
39.529
20.424
40.422
Employees
-
0
0
1
1
1
1
1
1
1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 81.4%, from 29.240 euro in the year 2023, to 52.752 euro in 2024.
The Net Profit increased by 20.113 euro, from 20.424 euro in 2023, to 40.422 in the last year.
Check the financial reports for the company - Medimarcprax Srl
Financial Rating - MEDIMARCPRAX SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Medimarcprax Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Medimarcprax Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Medimarcprax Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
42.619 euro in 2024 which includes Inventories of
0 euro, Receivables of
34.380 euro and cash availability of
8.239 euro.
The company's Equity was valued at
40.470 euro, while total Liabilities amounted to
3.521 euro.
Equity increased by 20.113 euro, from 20.472 euro in 2023, to 40.470 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medimarcprax Srl